MarketInOut Stock Screener Log In | Sign Up
 

GRAIL Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/16/2026
GRAIL Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6,050.49 mln
Float42.00 mln
Earnings Date11/18/2026

Piotroski F-Score

4 / 9
Borderline

Beneish M-Score

-2.19
Caution advised

1-Year Forecast

131.30
Modest upside

Relative Strength

16 / 100
Significantly lagging

Debt / Equity

0.04
Debt-free

Pre-Tax Margin

-320%
Severely loss-making

Business Description

GRAIL Inc. is a U.S.-based healthcare company focused on detecting multiple types of cancer at early stages through blood-based testing. Its flagship product, Galleri, screens for cancer in people over 50 who show no symptoms, while a separate test helps doctors reach faster conclusions for patients already suspected of having cancer. Founded in 2015 and based in Menlo Park, California, GRAIL also supports clinical research and offers tools that help track how cancer responds to treatment over time.

Key Fundamentals

EPS-9.36
ROE-16.08
RPS4.11
ROIC-19.06
ROA-13.86
EBITDA, mln-374
EV / EBITDA-14.67
EV / EBIT-10.37
Revenue, mln165
EV / Revenue33.22

Quote Details

Last 117.81
Change -17.65 (-13.03%)
Open 134.02
Volume 1,302,512
Turnover 153,448,928
Average Volume 1,541,017

Financial Ratios

Pre-Tax Profit Margin-320
Leverage Ratio1.12
Current Ratio10.95
Price / Book2.50
Price / Tangible Book8.36
Debt / Equity0.04
Price / Sales34.65

Financial Strength

Altman Z-Score6.83
Piotroski F-Score 4 / 9
Beneish M-Score-2.19
1-Year Target Price131.30
Short Ratio6.06
Short % of Float18.22

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -16.2% 13 / 100   
1 Month 56.85% 99 / 100   
2 Months 63.62% 98 / 100   
6 Months 138% 99 / 100   
1 Year 70.02% 95 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us